This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Genetic Technologies Ltd (GENE)

NASDAQ: Services

Company Cash Flow
Jun 2014 Jun 2013 Jun 2012 Jun 2011
Cash Flow From Operating Activities
Net Income (Loss) -9.54M -8.68M -5.42M 963.32K
Operating Gains/Losses 182.50K 405.49K -5.28M 305.45K
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -737.12K 155.27K 182.69K 85.81K
(Increase) Decrease in Inventories 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Current Assets 194.27K -178.00K -15.17K 0.00
(Decrease) Increase In Payables 69.34K 435.89K -214.30K -86.19K
(Decrease) Increase In Other Current Liabilities -221.81K 14.83K 0.00 -33.02K
(Increase) Decrease In Other Working Capital -748.99K 50.23K 194.72K 44.67K
Other Non-Cash Items 156.17K 319.28K 2.18M 558.81K
Net Cash From Continuing Operations -10.34M -6.97M -7.86M 2.39M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -10.34M -6.97M -7.86M 2.39M
Sale of Property, Plant & Equipment 0.00 1.11K 32.21K 154.66K
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -45.11K -49.74K -78.15K -149.28K
Acquisitions 0.00 -117.14K 10.00 0.00
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities -172.34K 0.00 549.97K 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities 218.78K -165.77K 504.04K 5.38K
Issuance of Debt 5.25M 0.00 1.02M 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 6.59M 446.78K 11.16M 0.00
Repayment of Long-Term Debt 0.00 -16.47K -1.08M -336.41K
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net -619.97K -23.94K 0.00 0.00
Net Cash From Financing Activities 11.23M 406.38K 11.11M -336.41K
Effect of Exchange Rate Changes -55.04K 72.87K 129.54K -133.80K
Net Change in Cash & Cash Equivalents 1.04M -6.66M 3.89M 1.92M

GENE Genetic Technologies Ltd

Analysts Ratings for GENE

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

GENE Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs